A BENEFICIAL EFFECT OF LONG-TERM TREATMENT OF RITUXIMAB IN INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS

被引：0
|
作者：
Ananyeva, Lidia
Koneva, Olga
Garzanova, Liudmila
Starovoytova, Mayya
Desinova, Oxana
Ovsyannikova, Olga
Shayakhmetova, Rushana
机构：
来源：
CHEST | 2022年 / 162卷 / 04期
关键词：
D O I：
10.1016/j.chest.2022.08.1800
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：2178A / 2178A
页数：1
相关论文
共 50 条
  • [1] LONG-TERM TREATMENT WITH RITUXIMAB IN INTERSTITIAL LUNG DISEASE RELATED TO SYSTEMIC SCLEROSIS: OUR CLINICAL EXPERIENCE
    Lumetti, F.
    Spinella, A.
    Ariani, A.
    Cocchiara, E.
    Colaci, M.
    Silva, M.
    Sverzellati, N.
    Ferri, C.
    Salvarani, C.
    Giuggioli, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 750 - 751
  • [2] THE EFFECT OF RITUXIMAB ON LUNG FUNCTION AND SKIN SCORE IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE. LONG-TERM OBSERVATION
    Garzanova, Liudmila
    Ananyeva, Lidia P.
    Koneva, Olga
    Desinova, Oxana
    Ovsyannikova, Olga
    Starovoytova, Mayya
    Volkov, Alexander
    Glukhova, Svetlana
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1213 - 1214
  • [3] LONG-TERM FOLLOW-UP OF PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE TREATED WITH RITUXIMAB
    Desinova, Oxana
    Starovoytova, Mayya
    Shayakhmetova, Rushana
    [J]. CHEST, 2021, 160 (04) : 1188A - 1188A
  • [4] RITUXIMAB FOR THE TREATMENT OF SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE: A CASE SERIES
    Ananyeva, L.
    Desinova, O.
    Starovoytova, M.
    Koneva, O.
    Yutkina, N.
    Onsyannikova, O.
    Volkov, A.
    Aleksandrova, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 648 - 648
  • [5] Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
    Mohammed, Abdel Gaffar A.
    Alshihre, Ammar
    Al-Homood, Ibrahim Abdulrazag
    [J]. ANNALS OF THORACIC MEDICINE, 2017, 12 (04) : 294 - 297
  • [6] Rituximab for the treatment of systemic sclerosis-interstitial lung disease
    Hughes, Michael
    Denton, Christopher P.
    Khanna, Dinesh
    [J]. RHEUMATOLOGY, 2021, 60 (02) : 489 - 491
  • [7] INTERSTITIAL LUNG DISEASE AND HEART MANIFESTATIONS ASSOCIATED WITH SYSTEMIC SCLEROSIS DURING RITUXIMAB TREATMENT
    Garzanova, Liudmila
    Ananyeva, Lidia
    Koneva, Olga A.
    Ovsyannikova, Olga
    Starovoytova, Mayya
    Desinova, Oxana
    Shayakhmetova, Rushana
    Khelkovskaya-Sergeeva, Anna
    [J]. CHEST, 2023, 164 (04) : 3110A - 3111A
  • [8] Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo
    Daoussis, Dimitrios
    Andonopoulos, Andrew P.
    [J]. RHEUMATOLOGY INTERNATIONAL, 2011, 31 (06) : 841 - 842
  • [9] Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo
    Dimitrios Daoussis
    Andrew P. Andonopoulos
    [J]. Rheumatology International, 2011, 31 : 841 - 842
  • [10] Efficacy of Rituximab in Systemic Sclerosis with Interstitial Lung Disease
    Onat, Ahmet Mesut
    Zengin, Orhan
    Aksoy, Savas
    Onder, Mustafa Erkut
    Sacinti, Koray Gorkem
    Kisacik, Bunyamin
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345